Nerea Menéndez-Coto

Ms. Nerea Menéndez-Coto


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YPYaiza Potes
Yaiza Potes
CVCristina Cachán Vega
Cristina Cachán Vega
EAEDUARDO ANTUÑA
EDUARDO ANTUÑA
CGClaudia Garcia-Gonzalez
Claudia Garcia-Gonzalez
NMNerea Menendez-Coto
Nerea Menendez-Coto
BEATRIZ CABALLERO GARCÍABEATRIZ CABALLERO GARCÍA
BEATRIZ CABALLERO GARCÍA
There are several neurological diseases under which processes related to adult brain neurogenesis, such cell proliferation, neural differentiation and neuronal maturation, are affected. Melatonin can exert a relevant benefit for treating neurological disorders, given its well-known antioxidant and anti-inflammatory properties as well as its pro-survival effects. In addition, melatonin is able to modulate cell proliferation and neural differentiation processes in neural stem/progenitor cells while improving neuronal maturation of neural precursor cells and newly created postmitotic neurons. Thus, melatonin shows relevant pro-neurogenic properties that may have benefits for neurological conditions associated with impairments in adult brain neurogenesis. For instance, the anti-aging properties of melatonin seem to be linked to its neurogenic properties. Modulation of neurogenesis by melatonin is beneficial under conditions of stress, anxiety and depression as well as for the ischemic brain or after a brain stroke. Pro-neurogenic actions of melatonin may also be beneficial for treating dementias, after a traumatic brain injury, and under conditions of epilepsy, schizophrenia and amyotrophic lateral sclerosis. Melatonin may represent a pro-neurogenic treatment effective for retarding the progression of neuropathology associated with Down syndrome. Finally, more studies are necessary to elucidate the benefits of melatonin treatments under brain disorders related to impairments in glucose and insulin homeostasis.

Verified
Journal Article
Open access
PDF file
EAEDUARDO ANTUÑA
EDUARDO ANTUÑA
YPYaiza Potes
Yaiza Potes
FHFrancisco Javier Baena Huerta
Francisco Javier Baena Huerta
CVCristina Cachán Vega
Cristina Cachán Vega
NMNerea Menendez-Coto
Nerea Menendez-Coto
CGClaudia Garcia-Gonzalez
Claudia Garcia-Gonzalez
Sarcopenia, a complex and debilitating condition characterized by progressive deterioration of skeletal muscle, is the primary cause of age-associated disability and significantly impacts healthspan in elderly patients. Despite its prevalence among the aging population, the underlying molecular mechanisms are still under investigation. The NLRP3 inflammasome is crucial in the innate immune response and has a significant impact on diseases related to inflammation and aging. Here, we investigated the expression of the NLRP3 inflammasome pathway and pro-inflammatory cytokines in skeletal muscle and peripheral blood of dependent and independent patients who underwent hip surgery. Patients were categorized into independent and dependent individuals based on their Barthel Index. The expression of NLRP3 inflammasome components was significantly upregulated in sarcopenic muscle from dependent patients, accompanied by higher levels of Caspase-1, IL-1β and IL-6. Among older dependent individuals with sarcopenia, there was a significant increase in the MYH3/MYH2 ratio, indicating a transcriptional shift in expression from mature to developmental myosin isoforms. Creatine kinase levels and senescence markers were also higher in dependent patients, altogether resembling dystrophic diseases and indicating muscle degeneration. In summary, we present evidence for the involvement of the NLRP3/ASC/NEK7/Caspase-1 inflammasome pathway with activation of pro-inflammatory SASP in the outcome of sarcopenia in the elderly.

Verified
Journal Article
Open access
PDF file
BLBeatriz de Luxán-Delgado
Beatriz de Luxán-Delgado
YPYaiza Potes
Yaiza Potes
ARAdrian Rubio-González
Adrian Rubio-González
JSJuan José Solano
Juan José Solano
José Antonio BogaJosé Antonio Boga
José Antonio Boga
IVIGNACIO VEGA-NAREDO
IGNACIO VEGA-NAREDO
Despite efforts to elucidate the cellular adaptations induced by obesity, cellular bioenergetics is currently considered a crucial target. New strategies to delay the onset of the hazardous adaptations induced by obesity are needed. Therefore, we evaluated the effects of 4 weeks of melatonin treatment on mitochondrial function and lipid metabolism in the livers of leptin-deficient mice. Our results revealed that the absence of leptin increased lipid storage in the liver and induced significant mitochondrial alterations, which were ultimately responsible for defective ATP production and reactive oxygen species overproduction. Moreover, leptin deficiency promoted mitochondrial biogenesis, fusion, and outer membrane permeabilization. Melatonin treatment reduced the bioenergetic deficit found in ob/ob mice, alleviating some mitochondrial alterations in the electron transport chain machinery, biogenesis, dynamics, respiration, ATP production, and mitochondrial outer membrane permeabilization. Given the role of melatonin in maintaining mitochondrial homeostasis, it could be used as a therapeutic agent against adipogenic steatosis.

Verified
Journal Article
Open access
PDF file
NMNerea Menendez-Coto
Nerea Menendez-Coto
CGClaudia Garcia-Gonzalez
Claudia Garcia-Gonzalez
FHFrancisco Javier Baena Huerta
Francisco Javier Baena Huerta
RZRubén Zapata-Pérez
Rubén Zapata-Pérez
RRRubén Rabadán
Rubén Rabadán
ACAna Coto-Montes
Ana Coto-Montes
Ageing leads to a gradual deterioration of the organs, with the brain being particularly susceptible, often leading to neurodegeneration. This process includes well-known changes such as tau hyperphosphorylation and beta-amyloid deposition, which are commonly associated with neurodegenerative diseases but are also present in ageing. These structures are triggered by earlier cellular changes such as energy depletion and impaired protein synthesis, both of which are essential for cell function. These changes may in part be induced by environmental pollution, which has been shown to accelerate these processes. Cold Atmospheric Plasma (CAP) or atmospheric pressure gas discharge plasmas have shown promise in activating the immune system and improving cellular function in vitro, although their effects at the organ level remain poorly understood. Our aim in this work is to investigate the effect of a device that combines CAP treatment with the effective removal of environmental nanoparticles, typical products of pollution, on the activity of aged mouse brains. The results showed an increase in energy capacity, a reduction in reticulum stress and an activation of cellular autophagic clearance, minimising aggresomes in the brain. This leads to a reduction in key markers of neurodegeneration such as tau hyperphosphorylation and beta-amyloid deposition, demonstrating the efficacy of the tested product at the brain level.

12 April 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
LLLucía González Llorente
Lucía González Llorente
Miguel Angel Andrés GascoMiguel Angel Andrés Gasco
Miguel Angel Andrés Gasco
MAMacarena Alba Gil Aranda
Macarena Alba Gil Aranda
RRRubén Rabadán
Rubén Rabadán
RZRubén Zapata-Pérez
Rubén Zapata-Pérez
ECEnrique Caso-Peláez
Enrique Caso-Peláez
Background/Objectives: The exposome, encompassing all environmental influences on health, plays a pivotal role in oxidative stress-related diseases. Negative air ions (NAIs), generated via cold atmospheric plasma (CAP), have been proposed as potential modulators of oxidative resilience. This study aims to investigate the metabolic adaptations induced by prolonged exposure to an NAI-enriched environment in mice, focusing on its effects in oxidative stress markers and energy metabolism in liver and blood. Methods: Twenty male C57BL/6J mice were divided into four groups: two experimental groups exposed to NAI-enriched air generated by an Air Cold Atmospheric Plasma–Nanoparticle Removal (aCAP-NR) device for either 18 days (short-term, ST) or 28 days (long-term, LT), and two control groups without exposure. Targeted metabolomics was performed in whole blood and liver using ultra-high-performance liquid chromatography–mass spectrometry (UHPLC-MS). Statistical and pathway analyses were conducted to assess metabolic alterations. Results: Metabolic profiling revealed significant shifts in oxidative stress-related pathways, including enhanced glutathione metabolism, reduced lipid peroxidation, and modulation of purine metabolism. Short-term exposure led to increased mitochondrial efficiency and energy homeostasis, while long-term exposure induced adaptive metabolic reprogramming, with higher inosine levels suggesting enhanced antioxidant and anti-inflammatory responses. No adverse effects on systemic or hepatic health markers were observed. Conclusions: NAI exposure via aCAP-NR elicits a hormetic response, enhancing metabolic efficiency and resilience to oxidative stress. These findings suggest that controlled environmental enrichment with NAIs may serve as a novel non-invasive strategy for mitigating oxidative damage and improving metabolic health, as hormetic adaptative capacity and resilience to oxidative stress, warranting further translational research.

18 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
BEATRIZ CABALLERO GARCÍABEATRIZ CABALLERO GARCÍA
BEATRIZ CABALLERO GARCÍA
EAEDUARDO ANTUÑA
EDUARDO ANTUÑA
CCCristina Cachán-Vega
Cristina Cachán-Vega
NYNasra Mohammed Yasin
Nasra Mohammed Yasin
Leo VeenmanLeo Veenman
Leo Veenman
MGMoshe Gavish
Moshe Gavish
We evaluated the effects of the TSPO ligand 2-Cl-MGV-1 on neurogenesis in a murine model with traumatic brain injury (TBI). Mice treated with 7.5 mg/kg of 2-Cl-MGV-1 for 60 days post-TBI showed reduced neuroinflammation and neurodegeneration in the cortex and hippocampus, as indicated by decreased TSPO expression. Notably, 2-Cl-MGV-1 modulated neurogenesis in a niche-specific manner. In the subventricular zone (SVZ), it enhanced neurogenic activity by increasing the expression of neural stem (Nestin) and progenitor (NeuroD1) cell markers, and by redirecting migration of neuroblasts from their canonical path to the olfactory bulb toward the injured cortex. This shift suggests an adaptive reparative response that facilitates brain recovery. In contrast, hippocampal neurogenesis was not enhanced; expression of Nestin, NeuroD1, and β-III-Tubulin in the dentate gyrus was reduced by 2-Cl-MGV-1. Nonetheless, hippocampal neuroprotection was observed, likely due to anti-inflammatory and anti-neurodegenerative effects of the treatment. These results reveal a niche-specific modulation of neurogenesis by 2-Cl-MGV-1, promoting regenerative activity by the ventricular neurogenesis while pre-serving hippocampal integrity through non-neurogenic mechanisms. Altogether, our findings support the therapeutic potential of 2-Cl-MGV-1 to improve brain recovery after TBI by reducing chronic responses post-injury and enhancing endogenous repair mecha-nisms in a neurogenic niche-specific manner.